Infosys Misses Revenue Targets, Names New CEO as AI Headwinds Intensify

What happened

Infosys reported weaker-than-expected quarterly revenue as clients curtailed spending amid disruptive shifts from artificial intelligence tools, reinforcing the cautious demand backdrop. Utilization (ex-trainees) slipped to 83.0% in Q4FY26 and headcount dropped sequentially, signaling that hefty large-deal wins ($15.0B TCV in FY26) are not translating into immediate delivery staffing. Management named a CEO designate, a leadership transition that adds another layer of uncertainty while the company navigates an AI-driven margin squeeze. The FY27 revenue guide of 1.5%–3.5% constant-currency growth and 20%–22% operating margin already embeds productivity pass-throughs, but today’s miss suggests near-term conversion may be even slower. The stock, already down ~41% from its 52-week high, now trades at 13.2x P/E with a net cash balance sheet, but the path to upside requires delivery metrics to stabilize and AI monetization to become visible.

Implication

Near-term headwinds are confirmed: the miss and CEO succession extend the period of uncertainty. The master report’s base case (2.5% CC growth, 21% margin) remains achievable, but the path is narrower given the demand caution. Long-term investors should monitor utilization (ex-trainees) and large-deal TCV in the next quarter; a sustained utilization below 83% would shift odds toward the bear case ($9.00). Until conversion improves or AI revenue disclosure emerges, the balance-sheet strength (net cash, robust buybacks) provides only a partial floor. Trim above $13.50 and add near $9.50, with a 3-6 month re-assessment window.

Thesis delta

The revenue miss and persistently low utilization (83.0%) confirm that AI productivity pass-throughs and cautious discretionary spending are weighing more heavily on near-term conversion than previously assumed, tilting the balance toward the bear case. The thesis now depends even more critically on whether large-deal TCV converts into higher staffing and margin stability within the next two quarters. Without that proof, the stock’s upside remains capped despite cheap multiples and strong capital returns.